Drinking one or more cans of sugary soft drinks a day is linked to an increased risk of diabetes in later life, a study suggests. A can a day raises… read more →
Abstract Offshoring of clinical trials is becoming an attractive business, and strategic models to facilitate cost efficient R&D processes and clinical trials. Based on the pharmaceutical industry’s data, the financial… read more →
Abstract Stakeholder is an intricate part of a clinical research. In many cases, without the stakeholder’s active-participatory role, a clinical research trial or an invention may not be possible. To… read more →
On 21 March 2013, the US State of Virginia signed into law a legislation allowing for the substitution of biosimilars, but with many restrictions, making it the first US… read more →
Most of the prescription drugs today give a short-term relief to patients thereby increasing the odds for patients to be addicted to prescription drugs. In addition, people who die from… read more →
The U.S. Supreme Court hears arguments Monday in a case worth billions of dollars to pharmaceutical companies and American consumers. The issue is whether brand-name drug manufacturers may pay generic… read more →
In pharmacology, “me-too” medicinal product is identical to a branded or generic version of a product in terms of its mode of action, mechanism of action or clinical pathway. Me-too… read more →
Abstract The most desirable benefit that patients will hope for in relation to the cost of pharmaceutical products are outcome reach and evaluation of improvements based of quality of life… read more →
Risk analysis is a systematic methodology used in an attempt to assess the hazardous or potential harm of an investigational product (Whitmore, 2004). Risk is a relative term in the… read more →
Abstract Human Epidermal Growth Factor Receptor 2 (HER-2) is a growth factor receptor encoded by ERBB2 gene, an avian erythroblastic leukemia viral oncogene homolog 2. The ERBB2 gene is located… read more →
Recent Comments